Maleimido-tri (ethylene glycol) -propionic acid
Maleimido-tri (ethylene glycol) -propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Maleimido-tri (ethylene glycol) -propionic acid is used for the preparation of neolymphostin-based ADC precursors for site-specific cysteine mutant trastuzumab-A114C conjugation[1]. Maleimido-tri (ethylene glycol) -propionic acid also can be used as a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Product Specifications
CAS Number
[518044-40-1]
Product Name Alternative
Mal-PEG3-acid
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
ADC Linker; PROTAC Linkers
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/maleimido-tri-ethylene-glycol-propionic-acid.html
Purity
99.14
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)CCOCCOCCOCCN1C(C=CC1=O)=O
Molecular Formula
C13H19NO7
Molecular Weight
301.29
Precautions
H302, H315, H319, H335
References & Citations
[1]Zhou D, et al. Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity.Bioorg Med Chem Lett. 2019 Apr 1;29 (7) :943-947.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Cleavable Linker; PEG Linkers
Available Sizes
Explore Other Products
Browse additional items from our catalog
Lentiviral human SCML1 shRNA (UAS) - Lentiviral human SCML1 shRNA (UAS, GFP) (25)
C1orf53 sgRNA CRISPR Lentivector (Human) (Target 3)
UBE4B (Ubiquitin Conjugation Factor E4 B, Homozygously Deleted in Neuroblastoma 1, HDNB1, KIAA0684, Ubiquitin Fusion Degradation Protein 2, UFD2) (MaxLight 490)
UBE4B (Ubiquitin Conjugation Factor E4 B, Homozygously Deleted in Neuroblastoma 1, HDNB1, KIAA0684, Ubiquitin Fusion Degradation Protein 2, UFD2) (MaxLight 490)